{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with recessive parkinsonism, suggesting loss of function is associated with disease, implying that PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used autophosphorylation assay to measure kinase activity, which is a standard technique in the field for assessing kinase function.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included basic controls (wild-type and kinase-dead mutants) and was performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used known pathogenic variants (L347P) and artificial kinase-dead mutants as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants and artificial kinase-dead mutants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The G309D mutation showed a decrease in kinase activity to 60.5% of wild type, with statistical significance (P = 0.01).",
          "judgment": "No",
          "reasoning": "Statistical analyses were sufficient to show a significant decrease in activity, but OddsPath was not calculated.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used a limited number of variant controls (less than 11 in total).",
          "judgment": "Yes",
          "reasoning": "Fewer than 11 total benign/pathogenic variant controls were used across the study.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G309D mutation in PINK1 shows a significant decrease in kinase activity, supporting its classification as pathogenic with supporting strength (PS3_supporting) due to the use of basic controls and replicates, but limited variant controls."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with recessive parkinsonism, suggesting loss of function is associated with disease, implying that PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used autophosphorylation assay to measure kinase activity, which is a standard technique in the field for assessing kinase function.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included basic controls (wild-type and kinase-dead mutants) and was performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used known pathogenic variants (G309D) and artificial kinase-dead mutants as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants and artificial kinase-dead mutants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The L347P mutation showed a drastic decrease in kinase activity (<10% of wild type) and was unstable in mammalian cells.",
          "judgment": "No",
          "reasoning": "Statistical analyses were sufficient to show a significant decrease in activity, but OddsPath was not calculated.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used a limited number of variant controls (less than 11 in total).",
          "judgment": "Yes",
          "reasoning": "Fewer than 11 total benign/pathogenic variant controls were used across the study.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L347P mutation in PINK1 shows a drastic decrease in kinase activity and protein stability, supporting its classification as pathogenic with supporting strength (PS3_supporting) due to the use of basic controls and replicates, but limited variant controls."
    }
  ]
}